{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:49:43Z","timestamp":1789148983667,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jdcr.2024.06.019","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T01:40:11Z","timestamp":1720143611000},"page":"7-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Recalcitrant cutaneous sarcoidosis treated with upadacitinib: Case report"],"prefix":"10.1016","volume":"51","author":[{"given":"Mohannad","family":"Safadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Whittington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-266X","authenticated-orcid":false,"given":"Scott","family":"Zahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tsoukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadera","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jdcr.2024.06.019_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.det.2023.02.012","article-title":"Cutaneous sarcoidosis","volume":"41","author":"Ezeh","year":"2023","journal-title":"Dermatol Clin"},{"issue":"11","key":"10.1016\/j.jdcr.2024.06.019_bib2","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/1756-185X.14441","article-title":"Tofacitinib for sarcoidosis, a new potential treatment","volume":"25","author":"Xu","year":"2022","journal-title":"Int J Rheum Dis"},{"issue":"16","key":"10.1016\/j.jdcr.2024.06.019_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612792","article-title":"Simultaneous assessment of mTORC1, JAK\/STAT, and NLRP3 inflammasome activation pathways in patients with sarcoidosis","volume":"24","author":"Kraaijvanger","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.jdcr.2024.06.019_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41584-022-00832-1","article-title":"Sarcoidosis: can tofacitinib slay the dragon?","volume":"18","author":"Sweiss","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.jdcr.2024.06.019_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jaad.2023.03.024","article-title":"Use of Janus kinase inhibitors for granulomatous dermatoses: a systematic review","volume":"89","author":"Sood","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jdcr.2024.06.019_bib6","article-title":"Recent clinical studies on the effects of tumor necrosis factor-alpha (TNF-\u03b1) and Janus kinase\/signal transducers and activators of transcription (JAK\/STAT) antibody therapies in refractory cutaneous sarcoidosis: a systematic review","volume":"15","author":"Toriola","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jdcr.2024.06.019_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/TCRM.S192922","article-title":"Refractory sarcoidosis: a review","volume":"16","author":"El Jammal","year":"2020","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.jdcr.2024.06.019_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.25259\/IJDVL_15_2023","article-title":"Janus-kinase inhibitors in dermatology: a review of their use in psoriasis, vitiligo, systemic lupus erythematosus, hidradenitis suppurativa, dermatomyositis, lichen planus, lichen planopilaris, sarcoidosis and\u00a0graft-versus-host disease","volume":"90","author":"Huang","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.jdcr.2024.06.019_bib9","first-page":"187","article-title":"The promise of JAK inhibitors for treatment of sarcoidosis and other inflammatory disorders with macrophage activation: a review of the literature","volume":"93","author":"Wang","year":"2020","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.jdcr.2024.06.019_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jdcr.2023.01.027","article-title":"A case of generalized granuloma annulare treated with upadacitinib","volume":"34","author":"Slater","year":"2023","journal-title":"JAAD Case Rep"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624002443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624002443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T11:56:22Z","timestamp":1726401382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512624002443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":10,"alternative-id":["S2352512624002443"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.06.019","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recalcitrant cutaneous sarcoidosis treated with upadacitinib: Case report","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}